Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tsunehiko Yamamoto
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The MafA Transcription Factor Becomes Essential to Islet -Cells Soon After Birth
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Effect of a Long-Term Behavioural Weight Loss Intervention on Nephropathy in Overweight or Obese Adults With Type 2 Diabetes: A Secondary Analysis of the Look AHEAD Randomised Clinical Trial
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Shrinkage of Pituitary Adenomas With Pasireotide
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Family Matters in Diabetes Care
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Potential Antitumour Activity of Pasireotide on Pituitary Tumours in Acromegaly
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Preoperative Prediction of Type 2 Diabetes Remission After Roux-En-Y Gastric Bypass Surgery: A Retrospective Cohort Study
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Sex-Specific Association Between BMI and Coronary Heart Disease: A Systematic Review and Meta-Analysis of 95 Cohorts With 1·2 Million Participants
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
An Active Life Is a Sweet Life
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Within-Trial Cost and 1-Year Cost-Effectiveness of the DiRECT/Counterweight-Plus Weight-Management Programme to Achieve Remission of Type 2 Diabetes
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Meta-Analysis of Artificial Pancreas Trials: Methodological Considerations
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
Health-Care Costs Over 15 Years After Bariatric Surgery for Patients With Different Baseline Glucose Status: Results From the Swedish Obese Subjects Study
The Lancet Diabetes and Endocrinology
Internal Medicine
Endocrinology
Metabolism
Diabetes
